Maze Therapeutics (MAZE) plunged ~37% on Wednesday despite reporting encouraging initial data from a Phase 2 trial for its lead asset, MZE829, targeted at broad APOL1-mediated kidney disease, a ...

Maze Therapeutics has revealed topline phase 2 data for its lead kidney disease candidate that has analysts heralding its “best-in-class potential.” The once-daily oral small molecule APOL1 inhibitor, ...

A Canadian who has worked in the gaming industry for over two decades, Beck grew up on games such as Final Fantasy and Super Mario Bros. He specalizes in roleplaying games, but covers titles in almost ...

The New York Times newsroom boasts a record 2,300 journalists, publisher AG Sulzberger said Thursday in his annual “State of the Times” address to employees. The newsroom tally underscores how the ...

Newly released documents show Washington voiced concerns months ago about the state’s budget proposals for reimbursement. The immigration detention center known as Alligator Alcatraz is seen in ...

OMAHA, Neb. (AP) — Six years after Warren Buffett sold off all of Berkshire Hathaway's newspapers and predicted unending declines for most of the industry, Berkshire disclosed a new $350 million ...

This is read by an automated voice. Please report any issues or inconsistencies here. Six years after Warren Buffett sold off all of Berkshire Hathaway’s newspapers and predicted unending declines for ...

The billionaire investor's company disclosed an investment in the Times valued at more than $350 million Tuesday. Buffett stepped aside as CEO last month. By Alex Weprin Senior Editor In Warren ...

Chief Medical Officer Harold Bernstein exercised 15,000 shares, which were sold immediately for a total transaction value of approximately $690,300 on Feb. 2, 2026. Maze Therapeutics recently hit its ...

The Seattle Times is offering a few ways to keep celebrating the Seahawks’ Super Bowl LX triumph over the New England Patriots, including with a copy of Monday’s paper, a poster of the front page and ...

Feb 4 (Reuters) - The New York Times (NYT.N), opens new tab on Wednesday posted slower digital subscriber growth for the fourth quarter and issued a lackluster ad revenue growth forecast, sending its ...

TheWrap/Christopher Smith/The New York Times Co. The New York Times saw its stock dip 9% as investors expressed concern about its spending, all while the paper pulled in $802.3 million in revenue in ...